$22.02
3.72% yesterday
NYSE, May 14, 10:14 pm CET
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Pfizer Stock price

$22.02
-0.10 0.45% 1M
-4.00 15.37% 6M
-4.51 17.00% YTD
-6.36 22.41% 1Y
-28.65 56.54% 3Y
-13.90 38.70% 5Y
-10.13 31.51% 10Y
NYSE, Closing price Wed, May 14 2025
-0.85 3.72%
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Key metrics

Market capitalization $125.19b
Enterprise Value $170.28b
P/E (TTM) P/E ratio 15.96
EV/FCF (TTM) EV/FCF 15.18
EV/Sales (TTM) EV/Sales 2.73
P/S ratio (TTM) P/S ratio 2.00
P/B ratio (TTM) P/B ratio 1.39
Dividend yield 7.67%
Last dividend (FY24) $1.69
Revenue growth (TTM) Revenue growth 13.38%
Revenue (TTM) Revenue $62.46b
EBIT (operating result TTM) EBIT $17.20b
Free Cash Flow (TTM) Free Cash Flow $11.22b
Cash position $17.32b
EPS (TTM) EPS $1.38
P/E forward 12.13
P/S forward 2.00
EV/Sales forward 2.72
Short interest 2.03%
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Pfizer forecast:

10x Buy
38%
15x Hold
58%
1x Sell
4%

Analyst Opinions

26 Analysts have issued a Pfizer forecast:

Buy
38%
Hold
58%
Sell
4%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
62,463 62,463
13% 13%
100%
- Direct Costs 20,654 20,654
27% 27%
33%
41,809 41,809
55% 55%
67%
- Selling and Administrative Expenses 7,281 7,281
9% 9%
12%
- Research and Development Expense 10,437 10,437
1% 1%
17%
24,091 24,091
190% 190%
39%
- Depreciation and Amortization 6,895 6,895
5% 5%
11%
EBIT (Operating Income) EBIT 17,196 17,196
867% 867%
28%
Net Profit 7,867 7,867
2,822% 2,822%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Positive
The Motley Fool
about 14 hours ago
With China and the United States finally talking to one another regarding tariffs, there's a glimmer of hope on the macroeconomic horizon. Investors might want to continue thinking and acting defensively though, given that we still don't exactly what the future holds.
Positive
Seeking Alpha
about 16 hours ago
Ongoing tariff disputes and President Trump's drug pricing order heighten uncertainties for AbbVie Inc. and Pfizer Inc. The more uncertain the time, the more investors should focus on return vectors that are less ambiguous. ABBV's superior dividend track record, safer payout ratio, consistent share buybacks, and robust margins make it an overall better package compared to PFE.
Neutral
Reuters
one day ago
Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO Albert Bourla on the purchase of billions of euros of COVID-19 vaccines.
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 81,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today